Daclizumab as escape therapy for late acute kidney rejection in the presence of FK506 nephrotoxicity
Published inTransplant international, vol. 13, no. 2, p. 169-171
Publication date2000
Keywords
- Acute Disease
- Adult
- Antibodies, Monoclonal/administration & dosage
- Antibodies, Monoclonal, Humanized
- Graft Rejection/prevention & control
- Humans
- Immunoglobulin G/administration & dosage
- Immunosuppressive Agents/administration & dosage/adverse effects
- Kidney Transplantation
- Male
- Tacrolimus/administration & dosage/adverse effects
- Transplantation, Homologous
Citation (ISO format)
OBERHOLZER, José et al. Daclizumab as escape therapy for late acute kidney rejection in the presence of FK506 nephrotoxicity. In: Transplant international, 2000, vol. 13, n° 2, p. 169–171. doi: 10.1007/s001470050317
Main files (1)
Article (Published version)
Identifiers
- PID : unige:55298
- DOI : 10.1007/s001470050317
- PMID : 10836657
Journal ISSN0934-0874
